http://www.bbcentre.eu/ |
Acronym: BBCE
Funding scheme: H2020-WIDESPREAD-04-2017-TeamingPhase1
Grant agreement No: 763721
Implementation period: 01.09.2017. – 31.08.2018
Project coordinator: Riga Technical University Rudolfs Cimdins Riga Biomaterials innovations and development centre, Latvia
Project partners:
AO Research Institute Davos, Switzerland
Friedrich-Alexander University of Erlangen-Nuremberg, Germany
Latvian Institute of Organic Synthesis, Latvia
Riga Stradins University, Latvia
Leader of Latvian team: Prof. Maija Dambrova
Total Costs: 397 623,75 EUR
EU contribution: 397 623,75 EUR
Costs for Latvian partner: 56 000,00 EUR
Summary
Ageing population puts high burden on society in terms of costs of healthcare and loss of quality of life. The need for bone and joint replacement implants is increasing with older age, and the musculoskeletal conditions are the second greatest cause of disability globally. The main objective of BBCE project is to establish the joint Baltic Biomaterials Centre of Excellence focused on the advanced biomaterial development for medical applications. Within the frame of critical mass formation in research and development, also the cooperation between industry and research organisations will be encouraged, leading to technology transfer and delivery of new products in to the market. BBCE is expected to ensure sustainable quality of the research and technology transfer potential in the field of biomaterials for medical applications, mainly focusing on research of biomaterials, advanced materials, nanotechnology, biomedicine and biopharmacy.